Tech Company Financing Transactions

PsychoGenics Funding Round

National Institute of Mental Health participated in a $3 million venture round for PsychoGenics. The round was announced on 8/28/2024.

Transaction Overview

Company Name
Announced On
8/28/2024
Transaction Type
Debt
Amount
$3,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the amount to develop eCube®, its proprietary AI-enabled EEG platform, along with its machine learning tools, to identify novel applications for existing drugs targeting rare diseases.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
215 College Road
Paramus, NJ 07652
USA
Email Address
Overview
PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next breakthroughs for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development.
Profile
PsychoGenics LinkedIn Company Profile
Social Media
PsychoGenics Company Twitter Account
Company News
PsychoGenics News
Facebook
PsychoGenics on Facebook
YouTube
PsychoGenics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Emer Leahy
  Emer Leahy LinkedIn Profile  Emer Leahy Twitter Account  Emer Leahy News  Emer Leahy on Facebook
Chief Scientific Officer
Mark Varney
  Mark Varney LinkedIn Profile  Mark Varney Twitter Account  Mark Varney News  Mark Varney on Facebook
Chief Technical Officer
Dani Brunner
  Dani Brunner LinkedIn Profile  Dani Brunner Twitter Account  Dani Brunner News  Dani Brunner on Facebook
Vice President
Stephen Morairty
  Stephen Morairty LinkedIn Profile  Stephen Morairty Twitter Account  Stephen Morairty News  Stephen Morairty on Facebook
Vice President
Sylvie Ramboz
  Sylvie Ramboz LinkedIn Profile  Sylvie Ramboz Twitter Account  Sylvie Ramboz News  Sylvie Ramboz on Facebook
Vice President
Leslie Street
  Leslie Street LinkedIn Profile  Leslie Street Twitter Account  Leslie Street News  Leslie Street on Facebook
VP - Bus. Development
David Bleakman
  David Bleakman LinkedIn Profile  David Bleakman Twitter Account  David Bleakman News  David Bleakman on Facebook
VP - Bus. Development
Taleen Hanania
  Taleen Hanania LinkedIn Profile  Taleen Hanania Twitter Account  Taleen Hanania News  Taleen Hanania on Facebook
VP - Finance
Ronald Christopher
  Ronald Christopher LinkedIn Profile  Ronald Christopher Twitter Account  Ronald Christopher News  Ronald Christopher on Facebook
VP - Human Resources
Kathleen Kelly
  Kathleen Kelly LinkedIn Profile  Kathleen Kelly Twitter Account  Kathleen Kelly News  Kathleen Kelly on Facebook
VP - R & D
Afshin Ghavami
  Afshin Ghavami LinkedIn Profile  Afshin Ghavami Twitter Account  Afshin Ghavami News  Afshin Ghavami on Facebook
VP - Regulatory Affairs
Christina Leahy
  Christina Leahy LinkedIn Profile  Christina Leahy Twitter Account  Christina Leahy News  Christina Leahy on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/28/2024: Pylon Labs venture capital transaction
Next: 8/28/2024: Comun venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary